Drug
Capivasertib
Capivasertib: highest development phase Phase 2, developed by Natera. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Natera
Trials
| Drug | Phase | Indication |
|---|---|---|
| Capivasertib NCT06613516 | Phase 2 | Breast Cancer |
Latest
No recent events.
Follow Capivasertib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.